Is bone grafting necessary? Analysis of twenty cases of giant cell tumour of bone treated by curettage without graft.
Twenty cases of giant-cell tumour of bone treated over an 11-year period were analysed. The minimum follow-up was 2 years. Primary treatment consisted of a detailed curettage alone, without bone grafting. A recurrence rate of 30% (six patients) was recorded. Cases of recurrence were suitable for resection and endoprosthetic replacement. We conclude that detailed curettage alone, without a bone graft, is an effective primary treatment for patients with giant-cell tumour of bone.
Waldram
M A
MA
Royal Orthopaedic Hospital, Northfield, Birmingham, Great Britain.
Sneath
R S
RS
D000293:Adolescent; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000601:surgery*; D016025:Bone Transplantation; D003475:Curettage; D005260:Female; D005266:Femoral Neoplasms / Q000601:surgery*; D005500:Follow-Up Studies; D005870:Giant Cell Tumors / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D013977:Tibia; D013997:Time Factors